FDA deals with backlog in latest spring clean
This article was originally published in Clinica
Executive Summary
The US FDA has begun to clear a backlog of unfinished projects, withdrawing 84 proposed actions and rules that were never finalised and are no longer public health priorities. Most proposals were originally made before 1997, and none have ever gone into effect.